« Previous
Next »
Neuromuscular Disorders
Volume 19, Issue 12
, Pages 828-832
, December 2009
Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations
References
- Congenital myasthenic syndromes and the formation of the neuromuscular junction. Ann NY Acad Sci. 2008;1132:99–103
- . Congenital myasthenic syndromes. In: Engel AG editors. Handbook of clinical neurology. Neuromuscular junction disorders. vol. 91:Elsevier; 2008;p. 285–331
- . Further observation in congenital myasthenic syndromes. Ann NY Acad Sci. 2008;1132:104–113
- Congenital myasthenic syndromes in childhood: diagnostic and management challenges. J Neuroimmunol. 2008;201–202:6–12
- . Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission. Expert Rev. 2007;9:1–20
- . Congenital myasthenic syndromes. J Clin Neurosci. 2009;16:1–11
- . The congenital myasthenic syndromes. J Neuroimmunol. 2008;15:201–202
- Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome. J Med Genet. 2009;46:203–208
- The muscle protein DOK-7 is essential for neuromuscular synaptogenesis. Science. 2006;312:1802–1805
- Dok-7 mutations underlie a neuromuscular junction synaptopathy. Science. 2006;3:1975–1978
- Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7. J Biol Chem. 2008;283:5518–5524
- Germline mutation in DOK7 associated with foetal akinesia deformation sequence. J Med Genet. 2009;46:338–340
- . Dok-7/MuSK signalling and a congenital myasthenic syndrome. Acta Myol. 2008;XXVII:25–29
- Variable phenotypes associated with mutations in DOK7. Muscle Nerve. 2008;37:448–456
- Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes. Brain. 2007;130:1497–1506
- Clinical features of the DOK7 neuromuscular junction synaptopathy. Brain. 2007;130:1507–1515
- Dok-7 myasthenia: phenotypic and molecular genetic studies in 16 patients. Ann Neurol. 2008;64:71–87
- . The therapy of congenital myasthenic syndromes. Neurotherapeutics. 2007;4:252–257
- . Therapeutic strategies in congenital myasthenic syndromes. Neurotherapeutics. 2008;5:542–547
- . Clinical trials in Duchenne dystrophy. I. The design of a protocol. Muscle Nerve. 1981;4:186–197
- Medical Research Council. Aids to the investigation of peripheral nerve injuries. War memorandum. Revised 2nd ed. London: HMSO; 1943.
- Congenital endplate acetylcholinesterase deficiency responsive to ephedrine. Neurology. 2005;65:144–146
- . Block of endplate acetylcholine receptor channel by the sympathomimetic agents ephedrine, pseudoephedrine and albuterol. Brain Res. 1996;18:346–352
- . Ephedrine: effects on neuromuscular transmission. Brain Res. 1993;623:167–171
- . 117th ENMC workshop: ventilatory support in congenital neuromuscular disorders – congenital myopathies, congenital muscular dystrophies, congenital myotonic dystrophy and SMA (II), 4–6 April 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004;14:56–69
- . Neuromuscular disorders. In: Hammer J, Eber E editor. Pediatric pulmonary function testing. Progress in respiratory research. vol. 33:Basel: Karger; 2005;p. 1–14
PII: S0960-8966(09)00622-1
doi: 10.1016/j.nmd.2009.09.008
© 2009 Elsevier B.V. All rights reserved.
« Previous
Next »
Neuromuscular Disorders
Volume 19, Issue 12
, Pages 828-832
, December 2009
